Baricitinib
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Antibiotics & Anti-Infectives treatment.
🧴 Clinical Application
Take orally once daily with or without food. In hospitalized COVID-19 protocols, typically prescribed for 14 days or until hospital discharge. Follow specialist's dosing recommendations based on renal clearance.
⚠️ Side Effects
Common: Upper respiratory tract infections, nausea, headache, elevated cholesterol levels, herpes simplex/zoster flares. Rare/Severe: Serious bacterial/fungal infections, deep vein thrombosis (DVT) and pulmonary embolism (PE), major adverse cardiovascular events (MACE), malignancies, and bowel perforation.
🛡️ Safety Warnings
Black box warnings: Serious infections, all-cause mortality, cardiovascular events, thrombosis, and malignancies. Screen for latent tuberculosis and viral hepatitis prior to use. Contraindicated in absolute lymphocyte count < 500, absolute neutrophil count < 1000, or hemoglobin < 8 g/dL.
Jan Aushadhi Products containing Baricitinib
Found 1 generic formulation(s) containing this active ingredient.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Baricitinib.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Baricitinib Tablets 4mg | 7's | Under Process | N/A | N/A | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Baricitinib generics.